Status | Study |
Recruiting |
Study Name: Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face Condition: Lentigo Maligna Date: 2016-03-15 Interventions: Drug: Picato gel apply on and 1 cm around the lesion, 0.47 g of Picato® gel 150 µg/g, once a d |
Recruiting |
Study Name: Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream Condition: Lentigo Maligna Date: 2016-02-13 Interventions: Drug: 5-aminolevulinic acid nanoemulsion A 1 millimeter thick layer of 5-aminolevulinic acid nanoemulsio |
Recruiting |
Study Name: Radiotherapy or Imiquimod in Complex Lentigo Maligna Condition: Lentigo Maligna Date: 2015-03-10 Interventions: Drug: Imiquimod Radiation: Radiotherapy |
Withdrawn |
Study Name: Mohs and Immunofluorescence for Malignant Melanoma In Situ Condition: Lentigo Maligna Melanoma In Situ Date: 2014-08-27 Interventions: Procedure: H&E Sample will |
Recruiting |
Study Name: Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face Condition: Lentigo Maligna Melanoma (Head or Neck) Date: 2012-10-23 Interventions: Drug: Imiquimod cream + surgery |
Completed |
Study Name: Effect of Topical Imiquimod on Lentigo Maligna Condition: Lentigo Maligna Date: 2010-06-24 Interventions: Drug: Imiquimod 250mg sachets to be applied at a start dose of 5 days a week. Dose will be adjusted usin |
Terminated |
Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma Condition: Acral Lentiginous Malignant Melanoma Lentigo Maligna Malignant Date: 2010-05-07 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Recruiting |
Study Name: Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna Condition: Lentigo Maligna Date: 2010-03-16 Interventions: Drug: Imiquimod Imiquimod 5% cream is applied once daily. Each patient will begin with the application 3 |
Active, not recruiting |
Study Name: Dinaciclib in Treating Patients With Stage IV Melanoma Condition: Acral Lentiginous Melanoma Lentigo Maligna Melanoma Date: 2009-07-10 Interventions: Drug: Dinaciclib Given IV Other Names: |
Completed |
Study Name: In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis Condition: Skin Cancer Melanoma Lentigo Maligna Date: 2008-11-04 Interventions: Device: Reflectance confocal microscopy Reflectance confocal microscopy (VivaScope 1500) |